nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—Progesterone—uterine cancer	0.0891	0.211	CbGbCtD
Maprotiline—ABCB1—Progesterone—uterine cancer	0.0779	0.184	CbGbCtD
Maprotiline—CYP2D6—Progesterone—uterine cancer	0.0734	0.174	CbGbCtD
Maprotiline—ABCB1—Dactinomycin—uterine cancer	0.0618	0.146	CbGbCtD
Maprotiline—CYP1A2—Etoposide—uterine cancer	0.0399	0.0942	CbGbCtD
Maprotiline—ABCB1—Etoposide—uterine cancer	0.0349	0.0824	CbGbCtD
Maprotiline—CHRM3—ureter—uterine cancer	0.0272	0.206	CbGeAlD
Maprotiline—ABCB1—Doxorubicin—uterine cancer	0.0238	0.0562	CbGbCtD
Maprotiline—CYP2D6—Doxorubicin—uterine cancer	0.0224	0.053	CbGbCtD
Maprotiline—CHRM3—muscle of abdomen—uterine cancer	0.0196	0.148	CbGeAlD
Maprotiline—HTR7—artery—uterine cancer	0.00585	0.0442	CbGeAlD
Maprotiline—CHRM3—exocrine gland—uterine cancer	0.00535	0.0405	CbGeAlD
Maprotiline—CHRM5—epithelium—uterine cancer	0.00417	0.0315	CbGeAlD
Maprotiline—HTR2A—artery—uterine cancer	0.00365	0.0276	CbGeAlD
Maprotiline—ORM1—endometrium—uterine cancer	0.00275	0.0208	CbGeAlD
Maprotiline—ORM1—female reproductive system—uterine cancer	0.00228	0.0172	CbGeAlD
Maprotiline—CHRM3—smooth muscle tissue—uterine cancer	0.00224	0.017	CbGeAlD
Maprotiline—HTR7—epithelium—uterine cancer	0.00222	0.0168	CbGeAlD
Maprotiline—SLC6A2—decidua—uterine cancer	0.00217	0.0164	CbGeAlD
Maprotiline—CHRM3—renal system—uterine cancer	0.00216	0.0163	CbGeAlD
Maprotiline—HTR7—smooth muscle tissue—uterine cancer	0.00214	0.0162	CbGeAlD
Maprotiline—HRH1—myometrium—uterine cancer	0.00211	0.0159	CbGeAlD
Maprotiline—HTR7—renal system—uterine cancer	0.00206	0.0156	CbGeAlD
Maprotiline—HTR2C—female reproductive system—uterine cancer	0.00205	0.0155	CbGeAlD
Maprotiline—CHRM1—female reproductive system—uterine cancer	0.00193	0.0146	CbGeAlD
Maprotiline—CHRM3—female reproductive system—uterine cancer	0.00173	0.0131	CbGeAlD
Maprotiline—SLC6A2—female reproductive system—uterine cancer	0.00171	0.0129	CbGeAlD
Maprotiline—HRH1—epithelium—uterine cancer	0.00166	0.0125	CbGeAlD
Maprotiline—HTR7—female reproductive system—uterine cancer	0.00165	0.0125	CbGeAlD
Maprotiline—HRH1—uterine cervix—uterine cancer	0.00164	0.0124	CbGeAlD
Maprotiline—CYP1A2—renal system—uterine cancer	0.00164	0.0124	CbGeAlD
Maprotiline—HRH1—smooth muscle tissue—uterine cancer	0.00159	0.0121	CbGeAlD
Maprotiline—CHRM3—female gonad—uterine cancer	0.00157	0.0119	CbGeAlD
Maprotiline—HRH1—decidua—uterine cancer	0.00156	0.0118	CbGeAlD
Maprotiline—HRH1—endometrium—uterine cancer	0.00148	0.0112	CbGeAlD
Maprotiline—HRH1—mammalian vulva—uterine cancer	0.00144	0.0109	CbGeAlD
Maprotiline—HTR2A—epithelium—uterine cancer	0.00138	0.0105	CbGeAlD
Maprotiline—ORM1—lymph node—uterine cancer	0.00133	0.0101	CbGeAlD
Maprotiline—HTR2A—smooth muscle tissue—uterine cancer	0.00133	0.0101	CbGeAlD
Maprotiline—HTR2A—renal system—uterine cancer	0.00128	0.0097	CbGeAlD
Maprotiline—HRH1—female reproductive system—uterine cancer	0.00123	0.0093	CbGeAlD
Maprotiline—CYP2D6—renal system—uterine cancer	0.00117	0.00883	CbGeAlD
Maprotiline—ABCB1—myometrium—uterine cancer	0.00115	0.00873	CbGeAlD
Maprotiline—HRH1—female gonad—uterine cancer	0.00112	0.00846	CbGeAlD
Maprotiline—HRH1—vagina—uterine cancer	0.00111	0.00841	CbGeAlD
Maprotiline—HTR2A—female reproductive system—uterine cancer	0.00103	0.00777	CbGeAlD
Maprotiline—SLC6A2—lymph node—uterine cancer	0.001	0.00756	CbGeAlD
Maprotiline—CYP2D6—female reproductive system—uterine cancer	0.000936	0.00708	CbGeAlD
Maprotiline—HTR2A—vagina—uterine cancer	0.000929	0.00702	CbGeAlD
Maprotiline—ABCB1—epithelium—uterine cancer	0.000906	0.00685	CbGeAlD
Maprotiline—ABCB1—uterine cervix—uterine cancer	0.000898	0.00679	CbGeAlD
Maprotiline—ABCB1—decidua—uterine cancer	0.000856	0.00647	CbGeAlD
Maprotiline—CYP2D6—female gonad—uterine cancer	0.000851	0.00644	CbGeAlD
Maprotiline—ABCB1—renal system—uterine cancer	0.00084	0.00636	CbGeAlD
Maprotiline—ABCB1—endometrium—uterine cancer	0.000812	0.00614	CbGeAlD
Maprotiline—Hypoaesthesia—Etoposide—uterine cancer	0.000805	0.00181	CcSEcCtD
Maprotiline—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000805	0.00181	CcSEcCtD
Maprotiline—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000805	0.00181	CcSEcCtD
Maprotiline—Urinary tract disorder—Etoposide—uterine cancer	0.000799	0.0018	CcSEcCtD
Maprotiline—Pruritus—Progesterone—uterine cancer	0.000795	0.00179	CcSEcCtD
Maprotiline—Oedema—Dactinomycin—uterine cancer	0.000794	0.00179	CcSEcCtD
Maprotiline—Urethral disorder—Etoposide—uterine cancer	0.000793	0.00178	CcSEcCtD
Maprotiline—Infection—Dactinomycin—uterine cancer	0.000789	0.00177	CcSEcCtD
Maprotiline—ABCB1—mammalian vulva—uterine cancer	0.000786	0.00594	CbGeAlD
Maprotiline—Thrombocytopenia—Dactinomycin—uterine cancer	0.000777	0.00175	CcSEcCtD
Maprotiline—Diarrhoea—Progesterone—uterine cancer	0.000769	0.00173	CcSEcCtD
Maprotiline—Erythema multiforme—Etoposide—uterine cancer	0.000765	0.00172	CcSEcCtD
Maprotiline—Eye disorder—Etoposide—uterine cancer	0.000756	0.0017	CcSEcCtD
Maprotiline—Cardiac disorder—Etoposide—uterine cancer	0.000751	0.00169	CcSEcCtD
Maprotiline—Flushing—Etoposide—uterine cancer	0.000751	0.00169	CcSEcCtD
Maprotiline—ABCB1—uterus—uterine cancer	0.000749	0.00566	CbGeAlD
Maprotiline—Dizziness—Progesterone—uterine cancer	0.000743	0.00167	CcSEcCtD
Maprotiline—Angiopathy—Etoposide—uterine cancer	0.000734	0.00165	CcSEcCtD
Maprotiline—Vascular purpura—Epirubicin—uterine cancer	0.000733	0.00165	CcSEcCtD
Maprotiline—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00073	0.00164	CcSEcCtD
Maprotiline—Mediastinal disorder—Etoposide—uterine cancer	0.000729	0.00164	CcSEcCtD
Maprotiline—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00072	0.00162	CcSEcCtD
Maprotiline—HRH1—lymph node—uterine cancer	0.000719	0.00544	CbGeAlD
Maprotiline—Alopecia—Etoposide—uterine cancer	0.000715	0.00161	CcSEcCtD
Maprotiline—Vomiting—Progesterone—uterine cancer	0.000714	0.00161	CcSEcCtD
Maprotiline—Rash—Progesterone—uterine cancer	0.000708	0.00159	CcSEcCtD
Maprotiline—Dermatitis—Progesterone—uterine cancer	0.000708	0.00159	CcSEcCtD
Maprotiline—Headache—Progesterone—uterine cancer	0.000704	0.00158	CcSEcCtD
Maprotiline—Hot flush—Epirubicin—uterine cancer	0.000701	0.00158	CcSEcCtD
Maprotiline—Increased appetite—Epirubicin—uterine cancer	0.000698	0.00157	CcSEcCtD
Maprotiline—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000697	0.00157	CcSEcCtD
Maprotiline—Menopausal symptoms—Epirubicin—uterine cancer	0.000695	0.00156	CcSEcCtD
Maprotiline—Dysgeusia—Etoposide—uterine cancer	0.00069	0.00155	CcSEcCtD
Maprotiline—Fatigue—Dactinomycin—uterine cancer	0.000685	0.00154	CcSEcCtD
Maprotiline—Purpura—Epirubicin—uterine cancer	0.00068	0.00153	CcSEcCtD
Maprotiline—Vascular purpura—Doxorubicin—uterine cancer	0.000678	0.00152	CcSEcCtD
Maprotiline—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000673	0.00151	CcSEcCtD
Maprotiline—ABCB1—female reproductive system—uterine cancer	0.000673	0.00509	CbGeAlD
Maprotiline—Cerebrovascular accident—Epirubicin—uterine cancer	0.000669	0.0015	CcSEcCtD
Maprotiline—Nausea—Progesterone—uterine cancer	0.000667	0.0015	CcSEcCtD
Maprotiline—Osteoarthritis—Epirubicin—uterine cancer	0.000655	0.00147	CcSEcCtD
Maprotiline—Feeling abnormal—Dactinomycin—uterine cancer	0.000654	0.00147	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000649	0.00146	CcSEcCtD
Maprotiline—Hot flush—Doxorubicin—uterine cancer	0.000648	0.00146	CcSEcCtD
Maprotiline—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000647	0.00146	CcSEcCtD
Maprotiline—Increased appetite—Doxorubicin—uterine cancer	0.000645	0.00145	CcSEcCtD
Maprotiline—Menopausal symptoms—Doxorubicin—uterine cancer	0.000643	0.00145	CcSEcCtD
Maprotiline—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000642	0.00144	CcSEcCtD
Maprotiline—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00144	CcSEcCtD
Maprotiline—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000638	0.00143	CcSEcCtD
Maprotiline—Leukopenia—Etoposide—uterine cancer	0.00063	0.00142	CcSEcCtD
Maprotiline—Purpura—Doxorubicin—uterine cancer	0.000629	0.00142	CcSEcCtD
Maprotiline—Body temperature increased—Dactinomycin—uterine cancer	0.000628	0.00141	CcSEcCtD
Maprotiline—Abdominal pain—Dactinomycin—uterine cancer	0.000628	0.00141	CcSEcCtD
Maprotiline—Loss of consciousness—Etoposide—uterine cancer	0.000619	0.00139	CcSEcCtD
Maprotiline—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000619	0.00139	CcSEcCtD
Maprotiline—Ataxia—Epirubicin—uterine cancer	0.000616	0.00139	CcSEcCtD
Maprotiline—ABCB1—female gonad—uterine cancer	0.000612	0.00463	CbGeAlD
Maprotiline—Convulsion—Etoposide—uterine cancer	0.00061	0.00137	CcSEcCtD
Maprotiline—ABCB1—vagina—uterine cancer	0.000609	0.0046	CbGeAlD
Maprotiline—Hypertension—Etoposide—uterine cancer	0.000608	0.00137	CcSEcCtD
Maprotiline—Osteoarthritis—Doxorubicin—uterine cancer	0.000606	0.00136	CcSEcCtD
Maprotiline—Liver function test abnormal—Epirubicin—uterine cancer	0.000605	0.00136	CcSEcCtD
Maprotiline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000605	0.00136	CcSEcCtD
Maprotiline—Orthostatic hypotension—Epirubicin—uterine cancer	0.000599	0.00135	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000595	0.00134	CcSEcCtD
Maprotiline—Breast disorder—Epirubicin—uterine cancer	0.000592	0.00133	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00059	0.00133	CcSEcCtD
Maprotiline—Confusional state—Etoposide—uterine cancer	0.000579	0.0013	CcSEcCtD
Maprotiline—Muscular weakness—Epirubicin—uterine cancer	0.000578	0.0013	CcSEcCtD
Maprotiline—Infection—Etoposide—uterine cancer	0.000571	0.00128	CcSEcCtD
Maprotiline—Ataxia—Doxorubicin—uterine cancer	0.00057	0.00128	CcSEcCtD
Maprotiline—Asthenia—Dactinomycin—uterine cancer	0.00057	0.00128	CcSEcCtD
Maprotiline—Dysphagia—Epirubicin—uterine cancer	0.000566	0.00127	CcSEcCtD
Maprotiline—Thrombocytopenia—Etoposide—uterine cancer	0.000563	0.00127	CcSEcCtD
Maprotiline—Tachycardia—Etoposide—uterine cancer	0.000561	0.00126	CcSEcCtD
Maprotiline—Eosinophilia—Epirubicin—uterine cancer	0.000561	0.00126	CcSEcCtD
Maprotiline—Liver function test abnormal—Doxorubicin—uterine cancer	0.00056	0.00126	CcSEcCtD
Maprotiline—Skin disorder—Etoposide—uterine cancer	0.000558	0.00126	CcSEcCtD
Maprotiline—Hyperhidrosis—Etoposide—uterine cancer	0.000556	0.00125	CcSEcCtD
Maprotiline—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000554	0.00125	CcSEcCtD
Maprotiline—Breast disorder—Doxorubicin—uterine cancer	0.000548	0.00123	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000546	0.00123	CcSEcCtD
Maprotiline—Diarrhoea—Dactinomycin—uterine cancer	0.000543	0.00122	CcSEcCtD
Maprotiline—Pancytopenia—Epirubicin—uterine cancer	0.000538	0.00121	CcSEcCtD
Maprotiline—Hypotension—Etoposide—uterine cancer	0.000537	0.00121	CcSEcCtD
Maprotiline—Muscular weakness—Doxorubicin—uterine cancer	0.000535	0.0012	CcSEcCtD
Maprotiline—Dysphagia—Doxorubicin—uterine cancer	0.000524	0.00118	CcSEcCtD
Maprotiline—Pollakiuria—Epirubicin—uterine cancer	0.000523	0.00118	CcSEcCtD
Maprotiline—Eosinophilia—Doxorubicin—uterine cancer	0.000519	0.00117	CcSEcCtD
Maprotiline—Photosensitivity reaction—Epirubicin—uterine cancer	0.000517	0.00116	CcSEcCtD
Maprotiline—Paraesthesia—Etoposide—uterine cancer	0.000516	0.00116	CcSEcCtD
Maprotiline—Weight increased—Epirubicin—uterine cancer	0.000516	0.00116	CcSEcCtD
Maprotiline—Weight decreased—Epirubicin—uterine cancer	0.000513	0.00115	CcSEcCtD
Maprotiline—Somnolence—Etoposide—uterine cancer	0.000511	0.00115	CcSEcCtD
Maprotiline—Infestation NOS—Epirubicin—uterine cancer	0.000505	0.00114	CcSEcCtD
Maprotiline—Drowsiness—Epirubicin—uterine cancer	0.000505	0.00114	CcSEcCtD
Maprotiline—Infestation—Epirubicin—uterine cancer	0.000505	0.00114	CcSEcCtD
Maprotiline—Vomiting—Dactinomycin—uterine cancer	0.000505	0.00114	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000501	0.00113	CcSEcCtD
Maprotiline—Rash—Dactinomycin—uterine cancer	0.000501	0.00113	CcSEcCtD
Maprotiline—Pancytopenia—Doxorubicin—uterine cancer	0.000498	0.00112	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Etoposide—uterine cancer	0.000496	0.00112	CcSEcCtD
Maprotiline—Fatigue—Etoposide—uterine cancer	0.000495	0.00111	CcSEcCtD
Maprotiline—Neuropathy peripheral—Epirubicin—uterine cancer	0.000495	0.00111	CcSEcCtD
Maprotiline—Jaundice—Epirubicin—uterine cancer	0.000492	0.00111	CcSEcCtD
Maprotiline—Stomatitis—Epirubicin—uterine cancer	0.000492	0.00111	CcSEcCtD
Maprotiline—Constipation—Etoposide—uterine cancer	0.000491	0.00111	CcSEcCtD
Maprotiline—Pollakiuria—Doxorubicin—uterine cancer	0.000484	0.00109	CcSEcCtD
Maprotiline—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000478	0.00108	CcSEcCtD
Maprotiline—Hepatobiliary disease—Epirubicin—uterine cancer	0.000478	0.00107	CcSEcCtD
Maprotiline—Weight increased—Doxorubicin—uterine cancer	0.000477	0.00107	CcSEcCtD
Maprotiline—Weight decreased—Doxorubicin—uterine cancer	0.000474	0.00107	CcSEcCtD
Maprotiline—Feeling abnormal—Etoposide—uterine cancer	0.000474	0.00107	CcSEcCtD
Maprotiline—Nausea—Dactinomycin—uterine cancer	0.000472	0.00106	CcSEcCtD
Maprotiline—Agranulocytosis—Epirubicin—uterine cancer	0.000471	0.00106	CcSEcCtD
Maprotiline—Gastrointestinal pain—Etoposide—uterine cancer	0.00047	0.00106	CcSEcCtD
Maprotiline—Drowsiness—Doxorubicin—uterine cancer	0.000467	0.00105	CcSEcCtD
Maprotiline—Infestation—Doxorubicin—uterine cancer	0.000467	0.00105	CcSEcCtD
Maprotiline—Infestation NOS—Doxorubicin—uterine cancer	0.000467	0.00105	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000463	0.00104	CcSEcCtD
Maprotiline—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000458	0.00103	CcSEcCtD
Maprotiline—Urticaria—Etoposide—uterine cancer	0.000457	0.00103	CcSEcCtD
Maprotiline—Stomatitis—Doxorubicin—uterine cancer	0.000456	0.00102	CcSEcCtD
Maprotiline—Jaundice—Doxorubicin—uterine cancer	0.000456	0.00102	CcSEcCtD
Maprotiline—Body temperature increased—Etoposide—uterine cancer	0.000454	0.00102	CcSEcCtD
Maprotiline—Abdominal pain—Etoposide—uterine cancer	0.000454	0.00102	CcSEcCtD
Maprotiline—Hepatitis—Epirubicin—uterine cancer	0.000453	0.00102	CcSEcCtD
Maprotiline—Hypoaesthesia—Epirubicin—uterine cancer	0.000451	0.00101	CcSEcCtD
Maprotiline—Urinary tract disorder—Epirubicin—uterine cancer	0.000448	0.00101	CcSEcCtD
Maprotiline—Urethral disorder—Epirubicin—uterine cancer	0.000444	0.001	CcSEcCtD
Maprotiline—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000442	0.000994	CcSEcCtD
Maprotiline—Agranulocytosis—Doxorubicin—uterine cancer	0.000436	0.000981	CcSEcCtD
Maprotiline—Erythema multiforme—Epirubicin—uterine cancer	0.000429	0.000964	CcSEcCtD
Maprotiline—Eye disorder—Epirubicin—uterine cancer	0.000424	0.000953	CcSEcCtD
Maprotiline—Tinnitus—Epirubicin—uterine cancer	0.000423	0.000951	CcSEcCtD
Maprotiline—Flushing—Epirubicin—uterine cancer	0.000421	0.000947	CcSEcCtD
Maprotiline—Cardiac disorder—Epirubicin—uterine cancer	0.000421	0.000947	CcSEcCtD
Maprotiline—Hepatitis—Doxorubicin—uterine cancer	0.00042	0.000944	CcSEcCtD
Maprotiline—Hypoaesthesia—Doxorubicin—uterine cancer	0.000417	0.000939	CcSEcCtD
Maprotiline—Urinary tract disorder—Doxorubicin—uterine cancer	0.000414	0.000932	CcSEcCtD
Maprotiline—Asthenia—Etoposide—uterine cancer	0.000412	0.000927	CcSEcCtD
Maprotiline—Angiopathy—Epirubicin—uterine cancer	0.000411	0.000925	CcSEcCtD
Maprotiline—Urethral disorder—Doxorubicin—uterine cancer	0.000411	0.000925	CcSEcCtD
Maprotiline—Mediastinal disorder—Epirubicin—uterine cancer	0.000409	0.000919	CcSEcCtD
Maprotiline—Pruritus—Etoposide—uterine cancer	0.000407	0.000915	CcSEcCtD
Maprotiline—Arrhythmia—Epirubicin—uterine cancer	0.000405	0.000911	CcSEcCtD
Maprotiline—Alopecia—Epirubicin—uterine cancer	0.000401	0.000901	CcSEcCtD
Maprotiline—Erythema multiforme—Doxorubicin—uterine cancer	0.000397	0.000892	CcSEcCtD
Maprotiline—Malnutrition—Epirubicin—uterine cancer	0.000395	0.000888	CcSEcCtD
Maprotiline—ABCB1—lymph node—uterine cancer	0.000394	0.00298	CbGeAlD
Maprotiline—Diarrhoea—Etoposide—uterine cancer	0.000393	0.000884	CcSEcCtD
Maprotiline—Eye disorder—Doxorubicin—uterine cancer	0.000392	0.000882	CcSEcCtD
Maprotiline—Tinnitus—Doxorubicin—uterine cancer	0.000391	0.00088	CcSEcCtD
Maprotiline—Flushing—Doxorubicin—uterine cancer	0.000389	0.000876	CcSEcCtD
Maprotiline—Cardiac disorder—Doxorubicin—uterine cancer	0.000389	0.000876	CcSEcCtD
Maprotiline—Tension—Epirubicin—uterine cancer	0.000387	0.000871	CcSEcCtD
Maprotiline—Dysgeusia—Epirubicin—uterine cancer	0.000387	0.000869	CcSEcCtD
Maprotiline—Nervousness—Epirubicin—uterine cancer	0.000383	0.000862	CcSEcCtD
Maprotiline—Angiopathy—Doxorubicin—uterine cancer	0.000381	0.000856	CcSEcCtD
Maprotiline—Dizziness—Etoposide—uterine cancer	0.00038	0.000855	CcSEcCtD
Maprotiline—Mediastinal disorder—Doxorubicin—uterine cancer	0.000378	0.00085	CcSEcCtD
Maprotiline—Arrhythmia—Doxorubicin—uterine cancer	0.000375	0.000843	CcSEcCtD
Maprotiline—Vision blurred—Epirubicin—uterine cancer	0.000372	0.000837	CcSEcCtD
Maprotiline—Alopecia—Doxorubicin—uterine cancer	0.000371	0.000834	CcSEcCtD
Maprotiline—Vomiting—Etoposide—uterine cancer	0.000365	0.000822	CcSEcCtD
Maprotiline—Malnutrition—Doxorubicin—uterine cancer	0.000365	0.000821	CcSEcCtD
Maprotiline—Agitation—Epirubicin—uterine cancer	0.000363	0.000816	CcSEcCtD
Maprotiline—Rash—Etoposide—uterine cancer	0.000362	0.000815	CcSEcCtD
Maprotiline—Dermatitis—Etoposide—uterine cancer	0.000362	0.000814	CcSEcCtD
Maprotiline—Headache—Etoposide—uterine cancer	0.00036	0.00081	CcSEcCtD
Maprotiline—Tension—Doxorubicin—uterine cancer	0.000358	0.000806	CcSEcCtD
Maprotiline—Dysgeusia—Doxorubicin—uterine cancer	0.000358	0.000804	CcSEcCtD
Maprotiline—Nervousness—Doxorubicin—uterine cancer	0.000355	0.000798	CcSEcCtD
Maprotiline—Syncope—Epirubicin—uterine cancer	0.000354	0.000796	CcSEcCtD
Maprotiline—Leukopenia—Epirubicin—uterine cancer	0.000353	0.000795	CcSEcCtD
Maprotiline—Palpitations—Epirubicin—uterine cancer	0.000349	0.000785	CcSEcCtD
Maprotiline—Loss of consciousness—Epirubicin—uterine cancer	0.000347	0.00078	CcSEcCtD
Maprotiline—Vision blurred—Doxorubicin—uterine cancer	0.000344	0.000774	CcSEcCtD
Maprotiline—Convulsion—Epirubicin—uterine cancer	0.000342	0.000769	CcSEcCtD
Maprotiline—Nausea—Etoposide—uterine cancer	0.000341	0.000768	CcSEcCtD
Maprotiline—Hypertension—Epirubicin—uterine cancer	0.000341	0.000767	CcSEcCtD
Maprotiline—Agitation—Doxorubicin—uterine cancer	0.000336	0.000755	CcSEcCtD
Maprotiline—Anxiety—Epirubicin—uterine cancer	0.000335	0.000753	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000334	0.000751	CcSEcCtD
Maprotiline—Dry mouth—Epirubicin—uterine cancer	0.000329	0.000739	CcSEcCtD
Maprotiline—Syncope—Doxorubicin—uterine cancer	0.000328	0.000737	CcSEcCtD
Maprotiline—Leukopenia—Doxorubicin—uterine cancer	0.000327	0.000735	CcSEcCtD
Maprotiline—Confusional state—Epirubicin—uterine cancer	0.000325	0.000731	CcSEcCtD
Maprotiline—Palpitations—Doxorubicin—uterine cancer	0.000323	0.000726	CcSEcCtD
Maprotiline—Oedema—Epirubicin—uterine cancer	0.000322	0.000725	CcSEcCtD
Maprotiline—Loss of consciousness—Doxorubicin—uterine cancer	0.000321	0.000722	CcSEcCtD
Maprotiline—Infection—Epirubicin—uterine cancer	0.00032	0.00072	CcSEcCtD
Maprotiline—Shock—Epirubicin—uterine cancer	0.000317	0.000713	CcSEcCtD
Maprotiline—Convulsion—Doxorubicin—uterine cancer	0.000316	0.000712	CcSEcCtD
Maprotiline—Nervous system disorder—Epirubicin—uterine cancer	0.000316	0.000711	CcSEcCtD
Maprotiline—Thrombocytopenia—Epirubicin—uterine cancer	0.000315	0.000709	CcSEcCtD
Maprotiline—Hypertension—Doxorubicin—uterine cancer	0.000315	0.000709	CcSEcCtD
Maprotiline—Tachycardia—Epirubicin—uterine cancer	0.000314	0.000707	CcSEcCtD
Maprotiline—Skin disorder—Epirubicin—uterine cancer	0.000313	0.000704	CcSEcCtD
Maprotiline—Hyperhidrosis—Epirubicin—uterine cancer	0.000311	0.0007	CcSEcCtD
Maprotiline—Anxiety—Doxorubicin—uterine cancer	0.00031	0.000697	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000309	0.000695	CcSEcCtD
Maprotiline—Dry mouth—Doxorubicin—uterine cancer	0.000304	0.000684	CcSEcCtD
Maprotiline—Hypotension—Epirubicin—uterine cancer	0.000301	0.000677	CcSEcCtD
Maprotiline—Confusional state—Doxorubicin—uterine cancer	0.000301	0.000676	CcSEcCtD
Maprotiline—Oedema—Doxorubicin—uterine cancer	0.000298	0.00067	CcSEcCtD
Maprotiline—Infection—Doxorubicin—uterine cancer	0.000296	0.000666	CcSEcCtD
Maprotiline—Shock—Doxorubicin—uterine cancer	0.000293	0.00066	CcSEcCtD
Maprotiline—Nervous system disorder—Doxorubicin—uterine cancer	0.000292	0.000657	CcSEcCtD
Maprotiline—Thrombocytopenia—Doxorubicin—uterine cancer	0.000292	0.000656	CcSEcCtD
Maprotiline—Insomnia—Epirubicin—uterine cancer	0.000291	0.000655	CcSEcCtD
Maprotiline—Tachycardia—Doxorubicin—uterine cancer	0.000291	0.000654	CcSEcCtD
Maprotiline—Skin disorder—Doxorubicin—uterine cancer	0.00029	0.000651	CcSEcCtD
Maprotiline—Paraesthesia—Epirubicin—uterine cancer	0.000289	0.000651	CcSEcCtD
Maprotiline—Hyperhidrosis—Doxorubicin—uterine cancer	0.000288	0.000648	CcSEcCtD
Maprotiline—Somnolence—Epirubicin—uterine cancer	0.000286	0.000644	CcSEcCtD
Maprotiline—Dyspepsia—Epirubicin—uterine cancer	0.000284	0.000638	CcSEcCtD
Maprotiline—Hypotension—Doxorubicin—uterine cancer	0.000279	0.000626	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000278	0.000626	CcSEcCtD
Maprotiline—Fatigue—Epirubicin—uterine cancer	0.000278	0.000625	CcSEcCtD
Maprotiline—Constipation—Epirubicin—uterine cancer	0.000275	0.00062	CcSEcCtD
Maprotiline—Insomnia—Doxorubicin—uterine cancer	0.00027	0.000606	CcSEcCtD
Maprotiline—Paraesthesia—Doxorubicin—uterine cancer	0.000268	0.000602	CcSEcCtD
Maprotiline—Feeling abnormal—Epirubicin—uterine cancer	0.000265	0.000597	CcSEcCtD
Maprotiline—Somnolence—Doxorubicin—uterine cancer	0.000265	0.000596	CcSEcCtD
Maprotiline—Gastrointestinal pain—Epirubicin—uterine cancer	0.000263	0.000593	CcSEcCtD
Maprotiline—Dyspepsia—Doxorubicin—uterine cancer	0.000262	0.00059	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000257	0.000579	CcSEcCtD
Maprotiline—Fatigue—Doxorubicin—uterine cancer	0.000257	0.000578	CcSEcCtD
Maprotiline—Urticaria—Epirubicin—uterine cancer	0.000256	0.000576	CcSEcCtD
Maprotiline—Constipation—Doxorubicin—uterine cancer	0.000255	0.000573	CcSEcCtD
Maprotiline—Body temperature increased—Epirubicin—uterine cancer	0.000255	0.000573	CcSEcCtD
Maprotiline—Abdominal pain—Epirubicin—uterine cancer	0.000255	0.000573	CcSEcCtD
Maprotiline—Feeling abnormal—Doxorubicin—uterine cancer	0.000246	0.000552	CcSEcCtD
Maprotiline—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000244	0.000548	CcSEcCtD
Maprotiline—Urticaria—Doxorubicin—uterine cancer	0.000237	0.000533	CcSEcCtD
Maprotiline—Abdominal pain—Doxorubicin—uterine cancer	0.000236	0.00053	CcSEcCtD
Maprotiline—Body temperature increased—Doxorubicin—uterine cancer	0.000236	0.00053	CcSEcCtD
Maprotiline—Asthenia—Epirubicin—uterine cancer	0.000231	0.00052	CcSEcCtD
Maprotiline—Pruritus—Epirubicin—uterine cancer	0.000228	0.000513	CcSEcCtD
Maprotiline—Diarrhoea—Epirubicin—uterine cancer	0.00022	0.000496	CcSEcCtD
Maprotiline—Asthenia—Doxorubicin—uterine cancer	0.000214	0.000481	CcSEcCtD
Maprotiline—Dizziness—Epirubicin—uterine cancer	0.000213	0.000479	CcSEcCtD
Maprotiline—Pruritus—Doxorubicin—uterine cancer	0.000211	0.000474	CcSEcCtD
Maprotiline—Vomiting—Epirubicin—uterine cancer	0.000205	0.000461	CcSEcCtD
Maprotiline—Diarrhoea—Doxorubicin—uterine cancer	0.000204	0.000459	CcSEcCtD
Maprotiline—Rash—Epirubicin—uterine cancer	0.000203	0.000457	CcSEcCtD
Maprotiline—Dermatitis—Epirubicin—uterine cancer	0.000203	0.000456	CcSEcCtD
Maprotiline—Headache—Epirubicin—uterine cancer	0.000202	0.000454	CcSEcCtD
Maprotiline—Dizziness—Doxorubicin—uterine cancer	0.000197	0.000443	CcSEcCtD
Maprotiline—Nausea—Epirubicin—uterine cancer	0.000191	0.00043	CcSEcCtD
Maprotiline—Vomiting—Doxorubicin—uterine cancer	0.00019	0.000426	CcSEcCtD
Maprotiline—Rash—Doxorubicin—uterine cancer	0.000188	0.000423	CcSEcCtD
Maprotiline—Dermatitis—Doxorubicin—uterine cancer	0.000188	0.000422	CcSEcCtD
Maprotiline—Headache—Doxorubicin—uterine cancer	0.000187	0.00042	CcSEcCtD
Maprotiline—Nausea—Doxorubicin—uterine cancer	0.000177	0.000398	CcSEcCtD
